Search Ontology:
ChEBI
N-{alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-yl-NHC(O)[CH2CH2O]4CH2CH2NHC(O)CH2CH2}maleimide
- Term ID
- CHEBI:137059
- Synonyms
-
- alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-N-[19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-17-oxo-4,7,10,13-tetraoxa-16-azanonadecanan-1-oyl]-beta-D-glucopyranosylamine
- alphaGal--EMCS
- maleimide-activated, thiol-reactive alphaGal
- O-alpha-D-galactopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-N-[19-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1,17-dioxo-4,7,10,13-tetraoxa-16-azanonadec-1-yl]-beta-D-glucopyranosylamine
- Definition
- A trisaccharide derivative in which a trisaccharide consisting of alpha-D-galactose, beta-D-galactose and beta-D-glucose residues linked sequentially (1->3) and (1->4), with the glucosyl residue at the reducing end being linked glycosidically to the terminal amide nitrogen of 19-maleimido-17-oxo-4,7,10,13-tetraoxa-16-azanonadecan-1-amide.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from N-{alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-yl-NHC(O)[CH2CH2O]4CH2CH2NHC(O)CH2CH2}maleimide
Phenotype where environments contain N-{alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-yl-NHC(O)[CH2CH2O]4CH2CH2NHC(O)CH2CH2}maleimide
Phenotype modified by environments containing N-{alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-yl-NHC(O)[CH2CH2O]4CH2CH2NHC(O)CH2CH2}maleimide
Human Disease Model